Shinichiro Suzuki
-
- Cancer Immunotherapy and Biomarkers 4
- Pancreatic and Hepatic Oncology Research 3
-
- Lung Cancer Treatments and Mutations 7
-
- Electrodeposition and Electroless Coatings 3
-
- Corrosion Behavior and Inhibition 3
-
- Gout, Hyperuricemia, Uric Acid 3
-
- Appendicitis Diagnosis and Management 2
-
- Gastrointestinal disorders and treatments 2
- Co-authors
- Hidetoshi HayashiKazuhiko NakagawaKazuko SakaiKazuto NishioJunko TanizakiKoji HarataniTaiki MorohashiToru Imai
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (3 papers)Clinical Cancer Research (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Shinichiro Suzuki
42 papers receiving 367 citations
Peers
Comparison fields: 5 of 90
- Oncology 105
- Pulmonary and Respiratory Medicine 95
- Otorhinolaryngology 11
- Gastroenterology 13
- Cancer Research 33
Countries citing papers authored by Shinichiro Suzuki
This map shows the geographic impact of Shinichiro Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Suzuki more than expected).
Fields of papers citing papers by Shinichiro Suzuki
This network shows the impact of papers produced by Shinichiro Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Suzuki. The network helps show where Shinichiro Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shinichiro Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 12 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 66 | |
| 6 | 2019 | 7 | |
| 7 | 2019 | 10 | |
| 8 | 2018 | 8 | |
| 9 | 2008 | 0 | |
| 10 | 1993 | 0 | |
| 11 | -469-THE ROLE OF PLASMA NORADRENALINE AND SERUM FREE FATTY ACID RELATED TO REDUCTION OF SERUM MAGNESIUM IN EARLY PHASE OF ACUTE MYOCARDIAL INFARCTION : Ischemic Heart Disease I : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY | 1989 | 1 |
| 12 | 1989 | 0 | |
| 13 | 1987 | 0 | |
| 14 | COMPARATIVE STUDIES OF LEFT VENTRICULAR PERFORMANCE AND CLINICAL FEATURES ANEURYSM, IN MEDICAL GROUP AND SURGICAL GROUP : Ischemic heart disease : FREE COMMUNICATIONS (Abstract) : 45 Annual Scientific Meeting, Japanese Circulation Society | 1981 | 1 |
| 15 | Vasodilatoly effects of Molsidomine in acute myocardial infarction | 1981 | 0 |
| 16 | 1966 | 2 | |
| 17 | 1964 | 1 | |
| 18 | 1964 | 2 | |
| 19 | 1963 | 2 | |
| 20 | 1961 | 4 |
About Shinichiro Suzuki
Shinichiro Suzuki is a scholar working on Nephrology, Gastroenterology and Oncology, having authored 54 papers that have together received 377 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Electrodeposition and Electroless Coatings (3 papers), Corrosion Behavior and Inhibition (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Appendicitis Diagnosis and Management (2 papers) and Gastrointestinal disorders and treatments (2 papers). The work is most often cited by research in Oncology (105 citations), Pulmonary and Respiratory Medicine (95 citations) and Otorhinolaryngology (11 citations). Shinichiro Suzuki has collaborated with scholars based in Japan and United States. Frequent co-authors include Hidetoshi Hayashi, Kazuhiko Nakagawa, Kazuko Sakai, Kazuto Nishio, Junko Tanizaki, Koji Haratani, Taiki Morohashi, Toru Imai, Chikako Tokoro and Yuji Fujita. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.